The U.S. Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,187,274 Project Grant to H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. to characterize plant-based phenolic alkanones as next-generation sun protectants for skin cancer prevention. The award commenced on July 15, 2024 and is set to be completed by July 14, 2027. Moffitt Cancer Center, a National Cancer Institute-designated comprehensive cancer center, will leverage its expertise in cancer biology, bioinformatics, biostatistics, and clinical trials to conduct this research initiative aimed at developing innovative sun protection solutions to reduce the incidence of skin cancer.
Generated 1/28/25, 10:56 AM